Evidence map›Paper›PMID 38037904›Full record

Observational studySubstance use & misuse2024

Understanding Regional Patterns of Overdose Deaths Related to Opioids and Psychostimulants.

Joel E Segel, Riley D Shearer, Abenaa A Jones, Utsha G Khatri, Benjamin A Howell, D Max Crowley, Glenn Sterner, Noel Vest, Daniel Teixeira da Silva, Tyler N A Winkelman

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Substance use & misuse, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Joel E SegelDepartment of Health Policy and Administration, Penn State University, University Park, Pennsylvania, USA.ORCID 0000-0001-8937-0531
Riley D ShearerDivision of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, Minnesota, USA.
Abenaa A JonesConsortium on Substance Use and Addiction, Penn State University, University Park, Pennsylvania, USA.ORCID 0000-0002-0819-4941
Utsha G KhatriDepartment of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Benjamin A HowellSEICHE Center for Health and Justice, Yale School of Medicine, New Haven, Connecticut, USA.
D Max CrowleyDepartment of Human Development and Family Studies, Penn State University, University Park, Pennsylvania, USA.
Glenn SternerConsortium on Substance Use and Addiction, Penn State University, University Park, Pennsylvania, USA.
Noel VestStanford University School of Medicine, Stanford, California, USA.ORCID 0000-0001-8014-9726
Daniel Teixeira da SilvaNational Clinician Scholars Program, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Tyler N A WinkelmanDivision of General Internal Medicine, Department of Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA.
Pennsylvania State University · USHennepin Healthcare Research Institute · USIcahn School of Medicine at Mount Sinai · USStanford University · USUniversity of Minnesota · USUniversity of Pennsylvania · US

Funding

Yale Drug use, Addiction and HIV Research Scholars (DAHRS)K12DA033312 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Patrick O'Connor · 2013 to 2026
$7.2M
Collegiate recovery programming in the U.S.: An implementation science and mixed methods studyK01DA053391 · NIDA · STANFORD UNIVERSITY · PI Noel Adam Vest · 2022 to 2026
$882k
Opioid Use Disorder among Criminal Justice-Involved Women: Integrating Trauma-Informed and Gender-Specific Care with Medication-Assisted TreatmentK01DA051715 · NIDA · PENNSYLVANIA STATE UNIVERSITY, THE · PI JONES, ABENAA ACHEAMPONG · 2020 to 2024
$809k
Characteristics and outcomes for hospitalized patients with methamphetamine and opioid co-use: Identifying opportunities for hospital-based addiction services tailored to co-useF30DA057775 · NIDA · UNIVERSITY OF MINNESOTA · PI Riley Shearer · 2023 to 2026
$171k
NIDA NIH HHS F30 DA057775NIDA NIH HHS K01 DA051715NIDA NIH HHS K01 DA053391NIDA NIH HHS K12 DA033312NIDA NIH HHS L30 DA056944
6 · The paper itself

Abstract

backgroundAs overdose rates increase for multiple substances, policymakers need to identify geographic patterns of substance-specific deaths. In this study, we describe county-level opioid and psychostimulant overdose patterns and how they correlate with county-level social vulnerability measures.

methodsA cross-sectional observational study, we used nationwide 2016-2018 restricted access Centers for Disease Prevention and Control county-level mortality files for 1,024 counties. We estimated quartiles of opioid and psychostimulant overdose mortality and provided estimates of their association with county-level Social Vulnerability Index (SVI) percentile.

resultsThere was high opioid and psychostimulant overdose mortality in the Middle Atlantic, South Atlantic, East North Central, and Mountain regions. The Central US had the lowest opioid and psychostimulant overdose mortality rates. Counties with higher SVI scores (i.e. higher social vulnerability) were significantly more likely to experience high opioid and high psychostimulant overdose (high-high) mortality. A 10-percentile increase in SVI score was associated with a 3.1 percentage point increase in the likelihood of being a high-high county (p < 0.001) in unadjusted models and a 1.5 percentage point increase (p < 0.05) in models adjusting for region.

conclusionOur results illustrated the heterogenous geographic distribution of the growing concurrent opioid and psychostimulant overdose crisis. The substantial regional variation we identified highlights the need for local data to guide policymaking and treatment planning. The association of opioid-psychostimulant overdose mortality with social vulnerability demonstrates the critical need in impacted counties for tailored treatment that addresses the complex medical and social needs of people who use both opioids and psychostimulants.

Indexed as

Central Nervous System StimulantsDrug OverdoseOpiate OverdoseOpioid-Related DisordersAnalgesics, OpioidCross-Sectional StudiesHumansAnalgesics, OpioidCentral Nervous System Stimulantscounty mortalityOpioidsoverdose mortalitypsychostimulantsocial vulnerability

Identifiers

PMID38037904
PMCPMC10923074
OpenAlexW4389236987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.